Wen Dong Selected Research

Antigens

1/2023	The NG2-glia is a potential target to maintain the integrity of neurovascular unit after acute ischemic stroke.
7/2021	Correction to: Lentivirus-mediated RNAi knockdown of prostate-specific membrane antigen suppresses growth, reduces migration ability and the invasiveness of prostate cancer cells.
1/2014	Prostate specific membrane antigen knockdown impairs the tumorigenicity of LNCaP prostate cancer cells by inhibiting the phosphatidylinositol 3-kinase/Akt signaling pathway.
9/2011	Lentivirus-mediated RNAi knockdown of prostate-specific membrane antigen suppresses growth, reduces migration ability and the invasiveness of prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wen Dong Research Topics

Disease

38	Neoplasms (Cancer) 10/2022 - 01/2005
19	Urinary Bladder Neoplasms (Bladder Cancer) 09/2023 - 09/2008
16	Ischemia 10/2023 - 10/2013
12	Neoplasm Metastasis (Metastasis) 12/2023 - 09/2008
9	Prostatic Neoplasms (Prostate Cancer) 07/2021 - 11/2010
8	Brain Ischemia (Cerebral Ischemia) 10/2023 - 05/2015
8	Ischemic Stroke 10/2023 - 08/2014
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2020
6	Lymphatic Metastasis 01/2022 - 01/2018
5	Renal Cell Carcinoma (Grawitz Tumor) 05/2023 - 04/2013
5	Stroke (Strokes) 01/2023 - 10/2015
4	Hypothermia 01/2022 - 04/2016
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 04/2010
4	Carcinogenesis 05/2019 - 04/2011
4	Body Weight (Weight, Body) 08/2018 - 09/2014
4	Kidney Neoplasms (Kidney Cancer) 10/2017 - 04/2013
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 01/2015
3	Lung Neoplasms (Lung Cancer) 12/2023 - 04/2016
3	Inflammation (Inflammations) 01/2023 - 03/2010
3	Leukemia 08/2022 - 12/2011
3	COVID-19 01/2022 - 01/2020
3	Infections 01/2020 - 10/2012
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2016 - 07/2014
3	Edema (Dropsy) 11/2016 - 06/2010
3	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 12/2014
3	Cognitive Dysfunction 04/2015 - 11/2014
2	Disease Progression 01/2024 - 07/2013
2	Necrosis 12/2023 - 03/2010
2	Adenocarcinoma 01/2023 - 01/2022
2	Transient Ischemic Attack 03/2022 - 04/2021
2	Adenocarcinoma of Lung 01/2022 - 01/2021
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2020 - 08/2014
2	Multiple Myeloma 04/2019 - 04/2010
2	Acute Kidney Injury (Acute Renal Failure) 12/2018 - 04/2016
2	Hyperoxia 10/2015 - 05/2015
2	Skin Neoplasms (Skin Cancer) 03/2013 - 02/2003
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2005 - 03/2003
1	Cleft Palate (Palate, Cleft) 03/2024
1	Glioma (Gliomas) 02/2024

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 05/2023 - 03/2003
7	Long Noncoding RNAIBA 01/2023 - 01/2017
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2014
4	Tyrosine Kinase InhibitorsIBA 12/2023 - 01/2021
4	AntigensIBA 01/2023 - 09/2011
4	Neuroprotective AgentsIBA 03/2022 - 01/2017
4	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 02/2010
4	LigandsIBA 01/2022 - 08/2015
4	Blood Glucose (Blood Sugar)IBA 08/2018 - 02/2010
3	Oxygen (Dioxygen)IBA 11/2023 - 10/2015
3	ZincIBA 10/2023 - 10/2015
3	Therapeutic UsesIBA 04/2023 - 09/2008
3	Peptides (Polypeptides)IBA 08/2022 - 11/2014
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2009
3	Messenger RNA (mRNA)IBA 01/2019 - 04/2011
3	Insulin (Novolin)FDA Link 08/2018 - 04/2015
3	CarcinogensIBA 06/2015 - 12/2005
3	MicroRNAs (MicroRNA)IBA 07/2013 - 03/2009
2	CrizotinibIBA 01/2024 - 12/2023
2	Indicators and Reagents (Reagents)IBA 11/2023 - 03/2022
2	pinitolIBA 01/2023 - 11/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2022
2	Small Interfering RNA (siRNA)IBA 02/2022 - 09/2011
2	Lysine (L-Lysine)FDA Link 01/2022 - 02/2015
2	Histones (Histone)IBA 01/2022 - 02/2015
2	histone H3 trimethyl Lys4IBA 01/2022 - 06/2021
2	B7-H1 AntigenIBA 06/2021 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 06/2021 - 02/2015
2	Polypyrimidine Tract-Binding ProteinIBA 03/2021 - 01/2019
2	RNA Splicing FactorsIBA 01/2021 - 01/2019
2	Circular RNAIBA 12/2019 - 12/2019
2	AndrogensIBA 01/2019 - 01/2017
2	CreatinineIBA 12/2018 - 04/2016
2	ResveratrolIBA 08/2018 - 01/2016
2	Malondialdehyde (Propanedial)IBA 01/2018 - 03/2010
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2016 - 07/2014
2	Chelating AgentsIBA 11/2016 - 10/2015
2	Evans Blue (Blue, Evans)FDA Link 11/2016 - 05/2015
2	N,N,N',N'- tetrakis(2- pyridylmethyl)ethylenediamineIBA 11/2016 - 10/2015
2	Insulin ReceptorIBA 08/2015 - 11/2014
2	Cyclin B1IBA 06/2015 - 02/2015
2	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 06/2015 - 01/2014
2	AD7c-NTPIBA 04/2015 - 12/2014
2	arseniteIBA 12/2011 - 04/2010
1	ElementsIBA 03/2024
1	6-methyladenineIBA 02/2024
1	entrectinibIBA 12/2023
1	Hematoxylin (Haematoxylon)IBA 12/2023
1	PolymersIBA 12/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2023
1	MetalsIBA 12/2023

Therapy/Procedure

17	Nephrectomy 10/2022 - 10/2012
11	Therapeutics 12/2023 - 04/2010
9	Warm Ischemia 01/2022 - 01/2013
5	Cystectomy 09/2023 - 09/2008
4	Drug Therapy (Chemotherapy) 01/2023 - 01/2019
3	Immunotherapy 01/2023 - 06/2021
3	Length of Stay 02/2020 - 10/2012
3	Caloric Restriction 01/2017 - 01/2015
2	Castration 01/2019 - 01/2017
1	Operative Surgical Procedures 03/2024